Cargando…

Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach

Acute myeloid leukemia (AML) is a disease, which mainly affects the elderly population. Unfortunately, the prognosis of patients aged >65 years is dismal, with 1-year overall survival approaching 10% with conventional therapies. The hypothesis of harnessing the immune system against cancer, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isidori, Alessandro, Loscocco, Federica, Ciciarello, Marilena, Corradi, Giulia, Lecciso, Mariangela, Ocadlikova, Darina, Parisi, Sarah, Salvestrini, Valentina, Amadori, Sergio, Visani, Giuseppe, Curti, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071222/ https://www.ncbi.nlm.nih.gov/pubmed/29932105 http://dx.doi.org/10.3390/cancers10070211

Ejemplares similares

The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
por: Parisi, Sarah, et al.
Publicado: (2017)

Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia
por: Ocadlikova, Darina, et al.
Publicado: (2019)

The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia
por: Ciciarello, Marilena, et al.
Publicado: (2019)

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival
por: Corradi, Giulia, et al.
Publicado: (2018)

PGE(2)-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit an In Vitro Antileukemic Immune Response
por: Trabanelli, Sara, et al.
Publicado: (2015)

BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
por: Loscocco, Federica, et al.
Publicado: (2019)

Emerging Bone Marrow Microenvironment-Driven Mechanisms of Drug Resistance in Acute Myeloid Leukemia: Tangle or Chance?
por: Ciciarello, Marilena, et al.
Publicado: (2021)

P1375: VENETOCLAX MODULATES TIM-3 EXPRESSION ON CD8 T CELLS IN ACUTE MYELOID LEUKEMIA PATIENTS
por: Ocadlikova, Darina, et al.
Publicado: (2023)

An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia
por: Ragaini, Simone, et al.
Publicado: (2022)

Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade
por: Ocadlikova, Darina, et al.
Publicado: (2021)

Treatment options for acute myeloid leukemia patients aged <60 years
por: Visani, Giuseppe, et al.
Publicado: (2022)

Immunotherapy in Acute Myeloid Leukemia: Where We Stand
por: Isidori, Alessandro, et al.
Publicado: (2021)

A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine
por: Ocadlikova, Darina, et al.
Publicado: (2020)

ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
por: Lecciso, Mariangela, et al.
Publicado: (2017)

PB1795: MESENCHYMAL STROMAL CELL-DEPENDENT ADHESION PATHWAYS PROTECT AML CELLS FROM VENETOCLAX-INDUCED APOPTOSIS
por: Ciciarello, Marilena, et al.
Publicado: (2023)

The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling
por: Forte, Dorian, et al.
Publicado: (2016)

The Human Mesenchymal Stromal Cell-Derived Osteocyte Capacity to Modulate Dendritic Cell Functions Is Strictly Dependent on the Culture System
por: Trabanelli, Sara, et al.
Publicado: (2015)

Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy
por: Ruggeri, Loredana, et al.
Publicado: (2015)

Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells
por: Salvestrini, Valentina, et al.
Publicado: (2020)

Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients
por: Chiarucci, Martina, et al.
Publicado: (2021)

Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells
por: Salvestrini, Valentina, et al.
Publicado: (2021)

Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
por: Loscocco, Federica, et al.
Publicado: (2021)

PB2379: SPECIFIC ALTERATIONS IN MEMBRANE LIPID LEVELS AS POTENTIAL BIOMARKERS IN DLBCL PATIENTS
por: Loscocco, Federica, et al.
Publicado: (2023)

Third Party Cord Blood Transplant Boosts Autologous Hematopoiesis in a Case of Persistent Bone Marrow Aplasia after Double Transplant Failure for B-Thalassemia Major
por: Visani, Giuseppe, et al.
Publicado: (2013)

Editorial: The Biological Landscape of Immunotherapy in AML
por: Isidori, Alessandro, et al.
Publicado: (2021)

Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
por: Bleve, Augusto, et al.
Publicado: (2022)

Immunosenescence and Vaccination
por: Pawelec, Graham
Publicado: (2005)

Mechanisms of immunosenescence
por: Caruso, Calogero, et al.
Publicado: (2009)

Immunosenescence and lymphomagenesis
por: Mancuso, Salvatrice, et al.
Publicado: (2018)

Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis
por: Visani, Giuseppe, et al.
Publicado: (2023)

Down syndrome, accelerated aging and immunosenescence
por: Gensous, Noémie, et al.
Publicado: (2020)

Myeloid Sarcoma: The Clinician's Point of View
por: Malagola, M., et al.
Publicado: (2011)

Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
por: Guolo, Fabio, et al.
Publicado: (2022)

Autologous Stem Cell Transplantation for Aggressive Lymphomas
por: Visani, Giuseppe, et al.
Publicado: (2012)

Robustness and Fragility in Immunosenescence
por: Stromberg, Sean P, et al.
Publicado: (2006)

Immunosenescence in vertebrates and invertebrates
por: Müller, Ludmila, et al.
Publicado: (2013)

Immunosenescence of Polymorphonuclear Neutrophils
por: Wessels, Inga, et al.
Publicado: (2010)

Immunosenescence in neurocritical care
por: Inoue, Shigeaki, et al.
Publicado: (2018)

Interleukin-7 and Immunosenescence
por: Nguyen, Vanloan, et al.
Publicado: (2017)

The untwining of immunosenescence and aging
por: Xu, Weili, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0s0ghq4ree5fibavedave51gqb